Kartikeya Cherabuddi, MD
Infectious Disease · Gainesville, FLNPI 1295053239
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Biofire Diagnostics, LLC accounts for 71.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $6,982 and has fallen 99.6% since, to $31 in 2025.
Across 11 payments — averaging $862.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biofire Diagnostics, LLC$7K
- Ferring Pharmaceuticals Inc.$2K
- Astellas Pharma US Inc$93
- AbbVie$77
- Shionogi Inc$35
- Cormedix Inc.$31
- plus $27 from 1 others
Across 13 payments — averaging $49,442 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arrow International, Inc.$429K
- Merck$189K
- Astrazeneca UK Limited$25K
What the payments were for
- Consulting fees$2,39025%
- Speaking & faculty fees$4,25045%
- Travel & lodging$2,54727%
- Food & beverage$2533%
- Education$481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biofire Diagnostics, LLC | 3 | $6,797 |
| Ferring Pharmaceuticals Inc. | 2 | $2,427 |
| Astellas Pharma US Inc | 1 | $93 |
| AbbVie | 1 | $77 |
| Shionogi Inc | 1 | $35 |
| Cormedix Inc. | 1 | $31 |
| Merck | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioFire FilmArray$6,232
- REBYOTA$2,390
- Film Array System$565
How this compares
$9,487 in reported general payments places this provider in the 85th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Gainesville
- Lennox ArchibaldGainesville$2.1M
- Cornelius ClancyGainesville$93K
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
- Douglas BrustMiami$359K
- Christopher CooperAltamonte Springs$278K
- Federico HinestrosaOrlando$276K
- Cynthia RiveraMiami Beach$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.